NCT05549492View on ClinicalTrials.gov

Transversus Abdominis Plane Block With or Without Buprenorphine After Inguinal Hernia Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

May 1, 2022

Study Completion Date

May 30, 2022

Conditions
Inguinal HerniaPain, Postoperative
Interventions
DRUG

Ropivacaine 0.25%-NaCl 0.9% Injectable Solution

"The pain level of the cases is evaluated by means of the digital pain (numeric rating) scale from 0 to 10 in which 0 means no pain and 10 means the worst pain as well as the duration of pain relief and the need for another dose of the same analgesic or other. The pain level is evaluated again if it is present."

Trial Locations (1)

Unknown

October 6 University Hospital, Giza

All Listed Sponsors
lead

Egymedicalpedia

INDUSTRY

NCT05549492 - Transversus Abdominis Plane Block With or Without Buprenorphine After Inguinal Hernia Surgery | Biotech Hunter | Biotech Hunter